Ubs Asset Management Americas Inc Ultragenyx Pharmaceutical Inc. Transaction History
Ubs Asset Management Americas Inc
- $345 Billion
- Q2 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 176,809 shares of RARE stock, worth $9.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
176,809
Previous 130,260
35.74%
Holding current value
$9.5 Million
Previous $6.08 Million
19.49%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding RARE
# of Institutions
287Shares Held
88.1MCall Options Held
505KPut Options Held
198K-
Vanguard Group Inc Valley Forge, PA9.78MShares$526 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$301 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.35MShares$288 Million0.68% of portfolio
-
Wellington Management Group LLP Boston, MA4.56MShares$245 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$175 Million2.24% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.76B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...